Search results
CureVac (NASDAQ:CVAC) Shares Down 4.8%
ETF DAILY NEWS· 7 days agoShares of CureVac (NASDAQ:CVAC – Get Free Report) traded down 4.8% during trading on Friday . The company traded as low as $4.67 and last traded at $4.75. 115,327 shares traded hands during ...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
Medical Xpress· 3 days agoIf you've been sick with COVID-19, you may have some protection against certain versions of the...
Paxlovid tied to 34% lower risk of hospitalization in adolescent COVID patients
Center for Infectious Disease Research and Policy· 5 days agoNo safety concerns were reported after Paxlovid use.
Another COVID vaccine? Yes, and here’s why
Denver Post· 4 days agoLast year’s shot isn’t holding up. Protection against both infection and severe illness is waning. “Effectiveness has decreased, as the time since...
Moderna’s flu-COVID combo shot hits goal in late-stage trial - Indianapolis Business Journal
Indianapolis Business Journal· 5 days agoModerna’s combination shot generated higher immune responses against the influenza virus and SARS-...
WHO confirms rare human case of bird flu infection in India
The Independent via Yahoo News· 4 days ago“Conjunctivitis...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
FOX 5 San Diego· 3 days agoIf you’ve been sick with COVID-19, you may have some protection against certain versions of the...
Past COVID infections may help protect against certain colds. Could it lead to better vaccines?
San Francisco Chronicle· 3 days agoIf you’ve been sick with COVID-19, you may have some protection against certain versions of the...
US government to fund up to $500 million for studies on oral, nasal COVID vaccines
Reuters via Yahoo News· 2 days agoThe funding is part of Project NextGen, a $5 billion initiative led by the Biomedical Advanced Research and Development Authority (BARDA), to advance a pipeline of new, innovative vaccines and ...
What causes long COVID? Case builds for rogue antibodies
Nature· 3 days agoStudy finds that antibodies from people with the debilitating condition trigger similar symptoms in...
